Monus Taylor, Howell Christopher M
At Kettering (Ohio) College, Taylor Monus is a student in the PA program, and Christopher M. Howell is an associate professor. The authors have disclosed no potential conflicts of interest, financial or otherwise.
JAAPA. 2019 Sep;32(9):1-5. doi: 10.1097/01.JAA.0000578812.47138.99.
Sickle cell disease (SCD) is a group of inherited blood disorders affecting the hemoglobin, shortening the lifespan of erythrocytes, and causing them to take on a distinctive sickled shape that can lead to vaso-occlusion. Current treatment aims to reduce morbidity and mortality through hydroxyurea, erythrocyte transfusion, and hematopoietic stem cell transplantation. This article reviews the disease process, typical presentations, complications, and acute and chronic treatment options.
镰状细胞病(SCD)是一组遗传性血液疾病,会影响血红蛋白,缩短红细胞寿命,并使其呈现出独特的镰刀状,进而导致血管阻塞。目前的治疗旨在通过羟基脲、红细胞输血和造血干细胞移植来降低发病率和死亡率。本文综述了该疾病的发病过程、典型表现、并发症以及急慢性治疗方案。